Literature DB >> 25441188

Randomisation is essential in Ebola drug trials.

David Shaw1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25441188     DOI： 10.1016/S0140-6736(14)61735-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Ebola: a holistic approach is required to achieve effective management and control.

Authors:  Anna Roca; Muhammed O Afolabi; Yauba Saidu; Beate Kampmann
Journal:  J Allergy Clin Immunol       Date:  2015-04       Impact factor: 10.793

2.  Ebola research funding: a systematic analysis, 1997-2015.

Authors:  Joseph Ra Fitchett; Amos Lichtman; Damilola T Soyode; Ariel Low; Jimena Villar de Onis; Michael G Head; Rifat Atun
Journal:  J Glob Health       Date:  2016-12       Impact factor: 4.413

Review 3.  A Systematic Review of Ebola Treatment Trials to Assess the Extent to Which They Adhere to Ethical Guidelines.

Authors:  Thomas Richardson; Andrew McDonald Johnston; Heather Draper
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

4.  Ethics review of studies during public health emergencies - the experience of the WHO ethics review committee during the Ebola virus disease epidemic.

Authors:  Emilie Alirol; Annette C Kuesel; Maria Magdalena Guraiib; Vânia de la Fuente-Núñez; Abha Saxena; Melba F Gomes
Journal:  BMC Med Ethics       Date:  2017-06-26       Impact factor: 2.652

Review 5.  Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?

Authors:  Simone Lanini; Alimuddin Zumla; John P A Ioannidis; Antonino Di Caro; Sanjeev Krishna; Lawrence Gostin; Enrico Girardi; Michel Pletschette; Gino Strada; Aldo Baritussio; Gina Portella; Giovanni Apolone; Silvio Cavuto; Roberto Satolli; Peter Kremsner; Francesco Vairo; Giuseppe Ippolito
Journal:  Lancet Infect Dis       Date:  2015-04-14       Impact factor: 25.071

6.  Use of Viremia to Evaluate the Baseline Case Fatality Ratio of Ebola Virus Disease and Inform Treatment Studies: A Retrospective Cohort Study.

Authors:  Oumar Faye; Alessio Andronico; Ousmane Faye; Henrik Salje; Pierre-Yves Boëlle; N'Faly Magassouba; Elhadj Ibrahima Bah; Lamine Koivogui; Boubacar Diallo; Alpha Amadou Diallo; Sakoba Keita; Mandy Kader Konde; Robert Fowler; Gamou Fall; Simon Cauchemez; Amadou Alpha Sall
Journal:  PLoS Med       Date:  2015-12-01       Impact factor: 11.069
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.